ATA58085A - Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen - Google Patents
Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungenInfo
- Publication number
- ATA58085A ATA58085A AT85580A AT58085A ATA58085A AT A58085 A ATA58085 A AT A58085A AT 85580 A AT85580 A AT 85580A AT 58085 A AT58085 A AT 58085A AT A58085 A ATA58085 A AT A58085A
- Authority
- AT
- Austria
- Prior art keywords
- alphaergocriptin
- bromine
- compositions
- producing
- bromine alphaergocriptin
- Prior art date
Links
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 title 1
- 229910052794 bromium Inorganic materials 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848405227A GB8405227D0 (en) | 1984-02-29 | 1984-02-29 | Bromocriptine compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA58085A true ATA58085A (de) | 1988-08-15 |
| AT387716B AT387716B (de) | 1989-03-10 |
Family
ID=10557324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0058085A AT387716B (de) | 1984-02-29 | 1985-02-27 | Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS60202812A (de) |
| AT (1) | AT387716B (de) |
| AU (2) | AU586621B2 (de) |
| BE (1) | BE901810A (de) |
| CA (1) | CA1256374A (de) |
| CH (2) | CH666406A5 (de) |
| DE (1) | DE3505743C2 (de) |
| DK (1) | DK175016B1 (de) |
| ES (1) | ES8705223A1 (de) |
| FR (1) | FR2560047B1 (de) |
| GB (1) | GB8405227D0 (de) |
| GR (1) | GR850506B (de) |
| HK (1) | HK85490A (de) |
| HU (1) | HU196121B (de) |
| IE (1) | IE58235B1 (de) |
| IL (1) | IL74459A (de) |
| IT (1) | IT1199948B (de) |
| LU (1) | LU85791A1 (de) |
| MX (1) | MX9203626A (de) |
| NL (1) | NL194231C (de) |
| NZ (1) | NZ211247A (de) |
| PH (1) | PH23266A (de) |
| PT (1) | PT80015B (de) |
| SE (2) | SE462259B (de) |
| SG (1) | SG69390G (de) |
| ZA (1) | ZA851546B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR850700212A (ko) * | 1984-03-21 | 1985-12-26 | 죠지 드모트 | 서방성 약제학적 캼셀제 |
| DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
| DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
| KR100321649B1 (ko) * | 1993-03-17 | 2002-07-22 | 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 | 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL128902C (de) * | 1960-06-06 | |||
| CH507249A (de) * | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
| DE2553026A1 (de) * | 1974-12-04 | 1976-06-10 | Schlueter Edelfett | Neue formulierungen |
| CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
| IT1158162B (it) * | 1977-12-22 | 1987-02-18 | Sandoz Ag | Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina |
| DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| DE3216870A1 (de) * | 1982-05-03 | 1983-11-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische zubereitungen mit zytostatischer wirkung |
| US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
-
1983
- 1983-12-14 CH CH6660/83A patent/CH666406A5/de not_active IP Right Cessation
-
1984
- 1984-02-29 GB GB848405227A patent/GB8405227D0/en active Pending
-
1985
- 1985-02-14 NL NL8500417A patent/NL194231C/nl not_active IP Right Cessation
- 1985-02-14 HU HU85555A patent/HU196121B/hu unknown
- 1985-02-20 DE DE3505743A patent/DE3505743C2/de not_active Expired - Lifetime
- 1985-02-20 IT IT47703/85A patent/IT1199948B/it active
- 1985-02-22 FR FR8502716A patent/FR2560047B1/fr not_active Expired
- 1985-02-22 CH CH830/85A patent/CH667009A5/de not_active IP Right Cessation
- 1985-02-25 BE BE1/11199A patent/BE901810A/fr not_active IP Right Cessation
- 1985-02-26 AU AU39136/85A patent/AU586621B2/en not_active Expired
- 1985-02-26 CA CA000475119A patent/CA1256374A/en not_active Expired
- 1985-02-26 DK DK198500867A patent/DK175016B1/da active Protection Beyond IP Right Term
- 1985-02-27 NZ NZ211247A patent/NZ211247A/xx unknown
- 1985-02-27 SE SE8500961A patent/SE462259B/sv unknown
- 1985-02-27 LU LU85791A patent/LU85791A1/fr unknown
- 1985-02-27 IL IL74459A patent/IL74459A/xx not_active IP Right Cessation
- 1985-02-27 PT PT80015A patent/PT80015B/pt unknown
- 1985-02-27 JP JP60040277A patent/JPS60202812A/ja active Granted
- 1985-02-27 AT AT0058085A patent/AT387716B/de not_active IP Right Cessation
- 1985-02-27 SE SE8500961D patent/SE8500961L/xx not_active Application Discontinuation
- 1985-02-27 GR GR850506A patent/GR850506B/el not_active IP Right Cessation
- 1985-02-28 PH PH31923A patent/PH23266A/en unknown
- 1985-02-28 ZA ZA851546A patent/ZA851546B/xx unknown
- 1985-02-28 ES ES540807A patent/ES8705223A1/es not_active Expired
- 1985-02-28 IE IE49585A patent/IE58235B1/en not_active IP Right Cessation
-
1989
- 1989-05-19 AU AU35006/89A patent/AU618599B2/en not_active Expired
-
1990
- 1990-08-22 SG SG693/90A patent/SG69390G/en unknown
- 1990-10-18 HK HK854/90A patent/HK85490A/xx not_active IP Right Cessation
-
1992
- 1992-06-26 MX MX9203626A patent/MX9203626A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3587442D1 (de) | Verfahren zur herstellung von polysilsesquioxanen. | |
| DE3581200D1 (de) | Verfahren zur herstellung von 1-hydroxyvitamin-d-verbindungen. | |
| DE3585687D1 (de) | Verfahren zur herstellung von 1-hydroxyvitamin-d-verbindungen. | |
| DE3586638D1 (de) | Verfahren zur herstellung von vanadylphthalocyanin. | |
| DE3575423D1 (de) | Verfahren zur herstellung von heteroaryloxyacetamiden. | |
| AT383808B (de) | Verfahren zur herstellung von penemen | |
| DE3578062D1 (de) | Verfahren zur herstellung von iodbenzol. | |
| AT379979B (de) | Verfahren zur herstellung von schleifmitteln | |
| ATA337285A (de) | Verfahren zur herstellung von isosilybinfreiem silibinin | |
| DE3585219D1 (de) | Verfahren zur herstellung von n-formyl-alpha-aspartyl-phenylalaninen. | |
| AT386829B (de) | Verfahren zur herstellung von imidazo-rifamycinen | |
| DE3579858D1 (de) | Verfahren zur herstellung von p-isobutylstyrol. | |
| DE3575133D1 (de) | Verfahren zur herstellung von 1-alkyl- oder 1-cycloalkylpiperazinen. | |
| DE3584754D1 (de) | Verfahren zur herstellung von arylalkylketonen. | |
| ATA199684A (de) | Verfahren zur herstellung von 6-deoxyanthracyclinonen | |
| DE3581667D1 (de) | Verfahren zur herstellung von 5-deoxy-l-arabinose. | |
| AT387716B (de) | Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen | |
| DE3576816D1 (de) | Verfahren zur herstellung von chlor-o-nitroanilinen. | |
| AT380480B (de) | Verfahren zur herstellung von anthracyclinglykosiden | |
| ATA178085A (de) | Verfahren zur herstellung von 1-thiosubstituierten n-methyl-2-nitroaethenaminen | |
| ATA252985A (de) | Verfahren zur herstellung von | |
| ATA25485A (de) | Verfahren zur herstellung von pteridinverbindungen | |
| DE3580751D1 (de) | Verfahren zur herstellung von acyl-lactam-verbindungen. | |
| AT384024B (de) | Verfahren zur herstellung von azinomethylrifamycinen | |
| AT381929B (de) | Verfahren zur herstellung von succinylobernstein- saeuredialkylestern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SZA | Application filed for a certificate of protection |
Free format text: SZ68/94, 941207 |
|
| SZZ | Certificate of protection withdrawn |
Free format text: SZ 68/94, 07121994 |
|
| ELA | Expired due to lapse of time |